OpenAI is generating approximately $25 billion in annualized revenue, raised $122 billion in its most recent round at an $852 billion valuation, and is the most searched pre-IPO company in the world right now. It is also one of the most complex to access before it goes public — because of its unusual corporate structure, its tight control over share transfers, and the fact that at $852 billion, you're not buying a discount to a future valuation. You're buying at or near the expected IPO price.

This guide explains the realistic access paths, what each route actually delivers, how OpenAI's corporate restructuring affects your rights as an investor, and what the timeline to liquidity looks like.

OpenAI's IPO Status as of June 2026

OpenAI has not filed a public S-1 as of mid-June 2026. The company is reportedly working with Goldman Sachs and Morgan Stanley on a confidential filing, with CFO Sarah Friar having signaled a late 2026 or 2027 listing window. The company is projecting a $14 billion loss in 2026 and does not expect profitability until 2029–2030.

The key complication for OpenAI's IPO is its ongoing conversion from a nonprofit-controlled structure to a public benefit corporation (PBC) — a legal restructuring that is still in progress as of mid-2026 and involves regulatory approvals and court proceedings (including a still-unresolved dispute with Elon Musk). Until that restructuring is complete, the path to public listing has structural dependencies that no investment bank timeline can guarantee.

OpenAI is generating $25 billion in annualized revenue at an $852 billion private valuation, but investors have reason to doubt the 2026 timeline — the company missed its own revenue targets, is in a court battle with Elon Musk, and CFO Sarah Friar has cautioned that OpenAI isn't ready to be a public company.

Bottom line on timing: Plan for a 2027 listing as the base case. A late 2026 window is possible but dependent on restructuring completion and market conditions.

What You're Actually Buying

Before exploring access paths, understand the asset. OpenAI's corporate structure is unlike any other pre-IPO company:

Nonprofit parent: OpenAI was founded as a nonprofit. The operating company (OpenAI Global, LLC) is a "capped-profit" subsidiary — investors can earn returns up to a defined cap, with excess profits going to the nonprofit mission. The conversion to a PBC changes this structure but is not yet final.

No voting rights in most secondary transactions: Secondary market purchases of OpenAI shares or SPV interests typically provide economic exposure only — not governance rights. Voting rights are retained by the company and its key principals.

Transfer restrictions and ROFR: Like most private companies, OpenAI maintains right of first refusal on secondary transfers. The company must approve or waive ROFR before any secondary transaction closes. This adds weeks to the transaction process and can kill deals.

What you're actually getting: Economic rights to participate in a future liquidity event (IPO, tender offer, acquisition). You're not getting a seat at the table, not getting voting rights, and not getting any guarantee of when or whether that liquidity event occurs.

The Three Legitimate Access Paths

Path 1: Secondary Market Platforms (Direct Shares)

Nasdaq Private Market estimates that OpenAI's price per share was $673.02 as of May 22, 2026. Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock.

Hiive also facilitates OpenAI secondary transactions. Pre-IPO marketplace data from Hiive and Caplight suggest the estimated valuation is above $720 billion as of Q2 2026, though the secondary marketplace is weakening as professional investors are starting to scrutinize OpenAI's numbers.

Who can use secondary platforms: Accredited investors and institutional buyers only. Individual accredited investors can access Hiive; Nasdaq Private Market primarily serves institutional buyers.

What to expect:

• Minimum transaction sizes of $100,000–$500,000

• ROFR process adds 3–6 weeks to close

• Pricing reflects real-time secondary supply/demand — currently at or above the $852B valuation implied by the last funding round

• Information asymmetry: you may receive less financial disclosure than in public markets. Pricing opacity: two buyers can see different "market" prices depending on lot size and urgency.

Path 2: SPVs (Special Purpose Vehicles)

Accredited investors can access OpenAI pre-IPO shares through three primary vehicles: SPVs that hold OpenAI shares in a Delaware LLC structure, direct secondary market purchases from existing shareholders subject to OpenAI's right of first refusal, and diversified pre-IPO funds with OpenAI exposure.

An SPV pools capital from multiple accredited investors into a single entity that purchases OpenAI shares on the secondary market. The SPV holds the shares; LPs own membership interests in the SPV. This approach lowers the per-investor minimum (typically $25,000–$100,000) and handles the ROFR and transfer coordination through the GP.

What to look for in an OpenAI SPV:

• Confirmation that underlying shares have already cleared ROFR (or that ROFR is pending with a known resolution timeline)

• GP carry of 10–20% — standard for single-deal SPVs; question anything above 20%

• No management fee on single-deal SPVs is the market norm

• Documentation of the GP's share acquisition — not just a "commitment" or "pipeline" position

Important: Some SPVs claim OpenAI "exposure" but hold interests in funds that hold OpenAI, rather than direct shares. Each additional layer adds fees and reduces the fidelity of your economic exposure. Ask explicitly: does this SPV hold OpenAI shares directly, or does it hold an interest in something that holds OpenAI?

Path 3: Funds with OpenAI Exposure

ARK Venture Fund (ARKVX): Holds OpenAI as one of its largest positions. Accessible to accredited investors with relatively low minimums and quarterly liquidity windows. The most institutionally managed and easiest to access for individual investors who don't want to navigate secondary market transactions directly.

Destiny Tech100 (DXYZ): NYSE-listed closed-end fund holding OpenAI, SpaceX, Anthropic, Stripe, and others. No accreditation required — accessible through any standard brokerage. Caveat: DXYZ has historically traded at a 50–200% premium to NAV, meaning you may be paying significantly more than the underlying OpenAI position is worth on a per-dollar basis.

Fundrise Innovation Fund: Lower minimum (~$10) with diversified private company exposure including OpenAI-adjacent names. More suitable for retail investors as a thematic bet than as a targeted OpenAI position.

The "OpenAI Tokens" Warning: What Not to Do

In May 2026, both OpenAI and Anthropic issued explicit warnings about tokenized products claiming to offer exposure to their shares. These products — issued by platforms like PreStocks on Solana — claim to hold shares through SPVs or forward contracts.

Tokens on Solana that claim to offer indirect exposure to OpenAI plunged almost 40% after the companies warned the structure behind them violates their share-transfer rules. The companies said the special purpose vehicles used to hold their stock without board approval are invalid and warned that third parties selling such exposure may be engaging in fraud or offering investments with no real value.

OpenAI's position: any SPV or transfer lacking explicit board approval is void and will not be recognized on its cap table. If you hold an "OpenAI token" or an unauthorized SPV interest, you hold a claim against the SPV operator — not against OpenAI's actual equity. If the company IPOs and the SPV isn't recognized, your economic rights may be worthless.

Rule: Only invest in OpenAI pre-IPO exposure through vehicles where the underlying share transfer has received explicit company approval. If a seller can't confirm that, don't invest.

Valuation Reality Check

At $852 billion (March 2026 funding round), OpenAI is already one of the most valuable companies in the world. The company is projected to lose $14 billion in 2026 and does not expect profitability until 2029–2030.

The bull case requires believing that:

• OpenAI maintains its leadership position in a rapidly competitive AI market (Google Gemini, Anthropic Claude, Meta Llama, xAI Grok are all viable alternatives)

• Revenue continues compounding from $25B to $100B+ within 3–5 years

• The structural shift to a PBC doesn't create governance complications that suppress the IPO valuation

• Public market investors will pay a premium to the $852B private valuation at IPO

The bear case: competitive commoditization of AI models, sustained losses at scale, delayed IPO forcing secondary market price correction, and PBC conversion complications.

Neither is guaranteed. At $852B, there is minimal margin for error. You're not buying a discount — you're buying conviction on the bull case at near-IPO prices, with illiquidity risk layered on top.

Accreditation and KYC Requirements

All legitimate OpenAI pre-IPO access requires verified accredited investor status:

• $200,000+ individual income or $300,000+ joint income in each of the past two years

• $1,000,000+ net worth excluding primary residence

• Series 7, 65, or 82 license in good standing

Under FinCEN's January 2026 AML/KYC rules, platforms and SPV administrators must collect and verify documentation — not rely on self-certification. Expect to pay at least a $10,000 investment minimum on most platforms, with SPVs typically starting at $25,000.

Tax Considerations

OpenAI investments through SPVs generate K-1 tax forms annually (arriving March–April, often requiring a return extension). At exit, gains held for more than one year qualify for long-term capital gains rates (20% federal + 3.8% NIIT for high earners).

QSBS: OpenAI does not qualify for Section 1202 QSBS exclusion given its scale. No capital gains exclusion is available.

IRA investing: Possible through a self-directed IRA with a custodian that supports private placements. See our IRA/SPV guide for mechanics.

Where Allocations Fits In

For GPs building OpenAI SPVs from legitimate, board-approved secondary share acquisitions, Allocations provides the formation, KYC/AML compliance, subscription management, and K-1 administration infrastructure. The platform's flat-fee structure means GPs retain 100% of their negotiated carry.

For LPs evaluating an Allocations-powered OpenAI SPV: the critical diligence question remains whether the underlying shares are board-approved transfers. Allocations handles the administrative layer; the authenticity of the underlying position is the GP's responsibility and yours to verify.

Frequently Asked Questions

Can I buy OpenAI stock before the IPO? Accredited investors can access OpenAI shares through secondary market platforms (Hiive, Nasdaq Private Market), board-approved SPVs, or funds like ARKVX. Non-accredited investors cannot access OpenAI directly before IPO.

When will OpenAI IPO? CFO Sarah Friar has signaled late 2026 or 2027 as the most likely window. The ongoing PBC conversion and court proceedings add timeline uncertainty. Do not invest expecting a 2026 exit.

Is the ARK Venture Fund a good way to get OpenAI exposure? ARKVX is the most accessible institutional-quality path to OpenAI exposure for individual accredited investors who don't want to navigate secondary market complexity. The tradeoff is diversified exposure across multiple companies rather than a pure OpenAI bet.

How do I know if an OpenAI SPV is legitimate? Require documentation that the underlying share transfer has received OpenAI board approval. Any SPV that can't confirm this may be holding void transfers with no recognized equity claim.

What is OpenAI's current share price? Nasdaq Private Market estimated OpenAI's price per share at $673.02 as of May 22, 2026. Secondary market prices fluctuate based on supply and demand and may be higher or lower at any given time.